| 20-03-02 | Dermira : Form 15-12B - Securities Registration Termination | PU |
| 20-02-20 | Dermira : SEC Filing - S-8 POS | PU |
| 20-02-20 | Dermira : SEC Filing - POS AM | PU |
| 20-02-20 | Dermira : Lilly Completes Acquisition of Dermira | PR |
| 20-02-11 | Dermira : Amended tender offer statement by Third Party | PU |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Thompson
PSD | President | - | - |
Carly Loeb
COO | Chief Operating Officer | - | 2017-12-31 |
Gary Thompson
CMP | Compliance Officer | - | 2017-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gordon Brooks
BRD | Director/Board Member | - | 2020-02-19 |
Philip Johnson
BRD | Director/Board Member | 61 | 2020-02-19 |
Michael Thompson
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20-02-19 | Don | Chief Medical Officer; Director | 562,325 | 1.0281% | ||
| 20-02-19 | Issuer sale | Director | 54,585 | 0.0998% | ||
| 20-02-19 | Don | Founder | 1,939,539 | 3.5461% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +0.11% | - | - | 1.03B | |
| +0.33% | +1.37% | +64.03% | +119.11% | 55.63B | |
| +0.82% | +15.05% | +79.93% | +84.34% | 52.25B | |
| +1.36% | +0.36% | -14.06% | -14.69% | 23.07B | |
| -1.04% | +7.91% | +1.61% | +419.24% | 22.41B | |
| -0.18% | +7.20% | +32.16% | -14.07% | 17.32B | |
| -1.10% | +4.00% | +28.70% | -34.51% | 15.94B | |
| -3.35% | +8.96% | +132.20% | +290.18% | 13.47B | |
| +2.89% | +5.51% | +27.11% | +181.45% | 13.77B | |
| +1.31% | +0.53% | +28.62% | - | 12.43B | |
| Average | +0.10% | +4.78% | +42.26% | +128.88% | 25.14B | |
| Weighted average by Cap. | +0.26% | +5.13% | +48.50% | +120.17% |
Employees
-
